Spatial immune architecture and immunotherapy resistance in microsatellite-stable colorectal cancer
Microsatellite-stable (MSS) colorectal cancer (CRC), which accounts for most metastatic CRC, remains largely resistant to immune checkpoint inhibitors. Although low tumor mutational burden and limited neoantigen generation contribute to this resistance, the spatial organization of the tumor microenvironment may also in...